CKD is one of the leading causes of death in the Philippines. The National Kidney Transplant Institute revealed that one Filipino develops chronic renal failure every hour. That is estimated to be at least 2.3 million Filipinos currently diagnosed with CKD. Other recent projections, meanwhile, show that one in 10 Filipinos will develop this deadly disease.
Practical steps for a healthier life
Managing your blood pressure begins with small steps that can have significant effects.
Lifestyle changes such as regular physical activity, managing stress, and avoiding smoking can contribute to healthy blood pressure. Transitioning to a well-balanced and heart-healthy diet can also help. A healthy diet is rich in fruits, vegetables, whole grains, and low in alcohol and food high in salt, saturated fats, and added sugars.
Additionally, it’s essential to get regular check-ups to monitor your health. Seeing a healthcare professional can alert you to changes in your blood pressure and can give you a better idea of where you stand so you can make changes when necessary.
“Hypertension and CKD are life-threatening conditions that often go unnoticed – but early detection and proper management can save lives. At Boehringer, we aim to improve the lives of people living with interconnected cardiovascular, renal, and metabolic (CRM) diseases through innovative and people-centric solutions. One of the best ways is to get yourself checked,” added Dr. Cortez.
In celebration of World Kidney Day this March, Boehringer Ingelheim Philippines emphasizes that taking small, consistent steps today can lead to a healthier tomorrow, such as getting checked for chronic kidney disease. Let 2025 be the year to protect your kidneys, care for your heart, and start living your best life.
To learn more about chronic kidney disease and how to get checked, go to https://itstartswithyou.com.ph.
A patient gets their blood pressure checked during the Get CheCKD event in Ayala Malls Manila Bay, highlighting the importance of early detection and regular monitoring in managing hypertension and preventing chronic kidney disease (CKD).
Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Learn more at https://www.boehringer-ingelheim.com.
